Antirheumatic drug toxicity in children

被引：0
|
作者：
不详
机构：
来源：
HOSPITAL MEDICINE | 1999年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [31] EXPERIENCES WITH NEW ANTIRHEUMATIC DRUG IN PRACTICE
    ZIEGELMAYER, W
    MEDIZINISCHE WELT, 1974, 25 (10): : 426 - 428
  • [32] Antirheumatic drug therapy during pregnancy
    Soscia, PN
    Zurier, RB
    BULLETIN ON THE RHEUMATIC DISEASES, 1997, 46 (02) : 2 - 4
  • [33] CHALLENGES IN DESIGNING ANTIRHEUMATIC DRUG TRIALS
    GOLDSMITH, CH
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (11) : 1643 - 1644
  • [34] REVIEW OF BENORYLATE - NEW ANTIRHEUMATIC DRUG
    WRIGHT, V
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1976, : 5 - 8
  • [35] WHAT IS A DISEASE MODIFYING ANTIRHEUMATIC DRUG
    HEPBURN, B
    JOURNAL OF RHEUMATOLOGY, 1988, 15 : 40 - 42
  • [36] THE RELATIVE TOXICITY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    FRIES, JF
    WILLIAMS, CA
    RAMEY, D
    BLOCH, DA
    ARTHRITIS AND RHEUMATISM, 1993, 36 (03): : 297 - 306
  • [37] THE TOXICITY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND ANTIRHEUMATIC DRUGS - AN INTRODUCTION
    BROOKS, PM
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (05) : 982 - 982
  • [38] UNIQUE PROPERTIES OF AURANOFIN AS A POTENTIAL ANTIRHEUMATIC DRUG
    BARRETT, ML
    LEWIS, GP
    AGENTS AND ACTIONS, 1986, 19 (1-2): : 109 - 115
  • [39] THE USE OF SULFASALAZINE AS A DISEASE MODIFYING ANTIRHEUMATIC DRUG
    PORTER, DR
    CAPELL, HA
    BAILLIERES CLINICAL RHEUMATOLOGY, 1990, 4 (03): : 535 - 557
  • [40] Effect of auranofin, an antirheumatic drug, on neutrophil apoptosis
    Liu, J
    Akahoshi, T
    Namai, R
    Matsui, T
    Kondo, H
    INFLAMMATION RESEARCH, 2000, 49 (09) : 445 - 451
12345